Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$10,229,939
+$1,131,698 QoQ
Shares Held
8,529
+0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,252
of 4,621 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUST CO OF VERMONT holds $143,988,175 across 14 Drug Manufacturers - General names. LLY ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
212,013 | $53,844,941 | |
| 2 | ABBV |
AbbVie Inc.
|
162,450 | $40,878,917 | |
| 3 | MRK |
Merck & Co., Inc.
|
106,435 | $13,676,897 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
8,529 | $10,229,939 | |
| 5 | AMGN |
Amgen Inc
|
22,744 | $8,236,057 | |
| 6 | NVS |
Novartis AG
|
46,466 | $7,282,150 | |
| 7 | PFE |
Pfizer Inc
|
158,728 | $3,822,169 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
49,346 | $2,843,316 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,229,939 | 8,529 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $9,098,241 | 8,466 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $6,854,029 | 8,983 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $7,027,462 | 9,015 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $7,116,866 | 8,617 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $6,684,748 | 8,659 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $7,191,174 | 8,117 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $7,503,789 | 8,288 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $6,345,819 | 8,157 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $4,042,550 | 6,935 | Shares | Sole | 2024-03-08 | |
| 2023-09-30 | $3,976,909 | 7,404 | Shares | Sole | 2023-11-27 | |
| 2023-06-30 | $3,445,596 | 7,347 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $2,537,530 | 7,389 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $2,737,214 | 7,482 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,324,563 | 7,189 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,433,994 | 7,507 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $2,191,302 | 7,652 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $2,139,047 | 7,744 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,718,087 | 7,436 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $1,740,449 | 7,583 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,413,479 | 7,566 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $1,436,996 | 8,511 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,259,797 | 8,511 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $1,416,216 | 8,626 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,268,871 | 9,147 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||